These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25212495)

  • 1. Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism.
    Chen RW; Harbour JW
    Graefes Arch Clin Exp Ophthalmol; 2014 Dec; 252(12):2021-2. PubMed ID: 25212495
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
    Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
    Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling and regression rate of irradiated uveal melanomas.
    Rao RC; Khan M; Badiyan SN; Harbour JW
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):333-7. PubMed ID: 25856819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
    Correa ZM; Huth B; Augsburger JJ
    Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
    Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaques.
    Schilling H; Bornfeld N; Friedrichs W; Pauleikhoff D; Sauerwein W; Wessing A
    Ger J Ophthalmol; 1994 Aug; 3(4-5):232-8. PubMed ID: 7804109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque radiotherapy for uveal melanoma.
    Shields JA; Shields CL; De Potter P; Cu-Unjieng A; Hernandez C; Brady LW
    Int Ophthalmol Clin; 1993; 33(3):129-35. PubMed ID: 8407177
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
    Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irradiated uveal melanomas: cytopathologic correlation with prognosis.
    Char DH; Kroll SM; Miller T; Castro J; Quivey J
    Am J Ophthalmol; 1996 Oct; 122(4):509-13. PubMed ID: 8862047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy.
    Brantley MA; Worley L; Harbour JW
    Am J Ophthalmol; 2002 Feb; 133(2):242-8. PubMed ID: 11812429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.
    Gupta K; McCannel CA; Kamrava M; Lamb J; Almanzor RD; McCannel TA
    Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1371-8. PubMed ID: 26907932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
    Quivey JM; Augsburger J; Snelling L; Brady LW
    Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proton therapy of uveal melanomas. Interview by H. Allouch].
    Desjardins L
    Presse Med; 2000 Apr 22-29; 29(15):842-4. PubMed ID: 10858115
    [No Abstract]   [Full Text] [Related]  

  • 15. Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy.
    Fang R; Wang H; Li Y; Liu YM; Wei WB
    BMC Ophthalmol; 2021 Mar; 21(1):137. PubMed ID: 33726696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma.
    Takiar V; Voong KR; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
    Pract Radiat Oncol; 2015; 5(3):e169-e176. PubMed ID: 25423888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
    Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
    J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.
    Saornil MA; Fisher MR; Campbell RJ; Robertson DM; Earle JD; Eagle RC; Shields JA; Shields CL; Chandra SR; Albert DM
    Arch Ophthalmol; 1997 Nov; 115(11):1395-400. PubMed ID: 9366669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas].
    Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
    Ophthalmologe; 2001 Aug; 98(8):736-42. PubMed ID: 11552413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
    Mruthyunjaya P; Seider MI; Stinnett S; Schefler A;
    Ophthalmology; 2017 Oct; 124(10):1532-1539. PubMed ID: 28549517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.